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OBJECTIVES The value of interventricular and intraventricular echocardiographic asynchrony parameters in
predicting reverse remodeling after cardiac resynchronization therapy (CRT) was investi-
gated.
BACKGROUND Cardiac resynchronization therapy has been suggested as a promising strategy in patients with
severe heart failure and left bundle branch block (LBBB), but the entity of benefit is variable
and no criteria are yet available to predict which patients will gain.
METHODS Interventricular and intraventricular mechanical asynchrony was evaluated in 20 patients (8
men and 12 women, 63  10 years) with advanced heart failure caused by ischemic (n  4)
or nonischemic dilated cardiomyopathy (n  16) and LBBB (QRS duration of at least 140
ms) using echocardiographic Doppler measurements. Left ventricular end-diastolic volume
index (LVEDVI) and left ventricular end-systolic volume index (LVESVI) were calculated
before and one month after CRT. Patients with a LVESVI reduction of at least 15% were
considered as responders.
RESULTS Cardiac resynchronization therapy significantly improved ventricular volumes (LVEDVI
from 150  53 ml/m2 to 119  37 ml/m2, p  0.001; LVESVI from 116  43 ml/m2 to
85  29 ml/m2, p  0.0001). At baseline, the responders had a significantly longer
septal-to-posterior wall motion delay (SPWMD), a left intraventricular asynchrony param-
eter; only QRS duration and SPWMD significantly correlated with a reduction in LVESVI
(r  0.54, p  0.05 and r  0.70, p  0.001, respectively), but the accuracy of SPWMD
in predicting reverse remodeling was greater than that of the QRS duration (85% vs. 65%).
CONCLUSIONS In patients with advanced heart failure and LBBB, baseline SPWMD is a strong predictor of
the occurrence of reverse remodeling after CRT, thus suggesting its usefulness in identifying
patients likely to benefit from biventricular pacing. (J Am Coll Cardiol 2002;40:1615–22)
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Chamber enlargement in patients with chronic heart failure
is often associated with asynchrony between right and left
ventricular contractions and within the left ventricle. Late
contraction of the left free wall gives rise to a further
worsening of hemodynamic function (1,2), which contrib-
utes to the development of ventricular remodeling (3). It has
been suggested that cardiac resynchronization therapy
(CRT), which involves the simultaneous stimulation of the
right ventricle and left free wall, reduces left ventricular
volumes and increases the ejection fraction (4–7). However,
the response in terms of reverse remodeling (7) and clinical
benefit (6–9) is heterogeneous and difficult to predict
(7,10–12).
Given the mechanisms by which resynchronization ther-
apy works, it can be speculated that the greater the asyn-
chrony, the greater the benefit. In clinical practice, a
prolonged QRS duration and, in particular, complete left
bundle branch block (LBBB) are regarded as the index of
ventricular asynchrony, guiding patient selection for CRT
(13). However, LBBB may not be precise enough to reflect
interventricular or intraventricular mechanical asynchrony
accurately and, if this is the case, the use of imaging
techniques to visualize ventricular asynchrony may do better
in identifying patients who will show reverse remodeling.
The aim of this prospective study was to evaluate whether
interventricular or intraventricular asynchrony parameters
identify patients with stable severe heart failure and LBBB
who are most likely to benefit from CRT in terms of reverse
remodeling.
METHODS
Study population. We studied patients with New York
Heart Association (NYHA) functional class III, chronic
heart failure of any origin who had been taking optimal drug
therapy for at least three months; all of them were in sinus
rhythm and had LBBB with a QRS duration 140 ms and
a left ventricular ejection fraction (LVEF) 35%. Their
condition had to be stable, without any spontaneous or
provoked angina, or the need for revascularization proce-
dures. The other exclusion criteria were acute heart failure,
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coronary artery bypass graft surgery or myocardial infarction
within the previous three months, valvular stenosis, previous
valve replacement or reconstruction, the presence of a
pacemaker or any indication for one, or a history of chronic
atrial fibrillation.
The study was approved by the local ethics committee,
and all of the patients gave written, informed consent.
Protocol. Between 10 and 5 days before implantation, all
of the patients underwent a clinical examination, 12-lead
electrocardiography (ECG), and mono-dimensional and
two-dimensional echocardiographic and Doppler evalua-
tions. The same evaluations were repeated one month after
implantation (during which time care was taken to keep the
drug treatment unchanged), when the patients were paced
using the optimal mode and settings. The QRS duration
was measured as the maximum of leads II, V1, and V6; the
PQ interval duration was calculated as the longest interval
found on the 12-lead ECG.
ECHOCARDIOGRAPHIC EXAMINATION. Mono-dimensional
and two-dimensional echocardiography recordings were
made using a phased-array echocardiographic Doppler sys-
tem (Sonos 5500, Hewlett-Packard [Agilent], Andover,
Massachusetts) equipped with a 3-MHz transducer. Briefly,
after resting for 10 min, the patients were examined in the
left lateral recumbent position using standard parasternal
short- and long-axis and apical views. Left ventricular
end-diastolic and end-systolic volumes were calculated us-
ing Simpson’s rule (14) and indexed for body surface area.
Reverse remodeling was assessed on the basis of the reduc-
tion in the left ventricular end-systolic volume index
(LVESVI). The patients were considered as responders if
LVESVI decreased by 15%, and as nonresponders in all
other cases (7,15). Left ventricular systolic function was
evaluated using LVEF (14). Mitral regurgitation (MR) was
quantified by calculating the area (MRa) and duration
(MRd) of the regurgitation (16).
Intraventricular asynchrony was evaluated on the basis of
the left ventricular electromechanical delay (LVEMD) (i.e.,
the time [ms] from QRS onset to aortic flow onset) (6) and
the delay between the motion of the septum and left
posterior wall (septal-to-posterior wall motion delay [SP-
WMD]; ms), calculated as the shortest interval between the
maximal posterior displacement of the septum and the
maximal displacement of the left posterior wall using a
mono-dimensional short-axis view at the papillary muscle
level (Fig. 1). Interventricular asynchrony (interventricular
delay [IVD]; ms) was evaluated on the basis of the delay in
LVEMD in comparison with the right electromechanical
delay (measured as the time between the simultaneously
recorded onset of the QRS interval and pulmonary flow)
(6).
The intraobserver and interobserver reproducibilities of
all of the aforementioned echocardiographic measures of
asynchrony were calculated.
The data obtained before implantation were compared
with those found during follow-up by two skilled and
independent operators (R. R. and B. R.), who were unaware
of the baseline interventricular and intraventricular conduc-
tion delays.
PACEMAKER IMPLANTATION. Twenty-one consecutive pa-
tients were implanted with a biventricular pacemaker
(Guidant Contak TR CHFD, Guidant Inc., St. Paul,
Minnesota or Medtronic InSync III 8040, Medtronic Inc.,
Minneapolis, Minnesota), and four received a biventricular
cardioverter-defibrillator (Guidant Contak CD CHFD or
Contak Renewal, Guidant Inc.; or Medtronic InSync ICD
7272, Medtronic Inc.). Left ventricular pacing was obtained
transvenously in all cases. After coronary sinus angiography,
a unipolar lead with an over-the-wire system (Easytrak,
Guidant Inc. or Medtronic 4193-78, Medtronic Inc.) was
advanced into the lateral or posterolateral cardiac vein. The
final position was chosen on the basis of visual inspection by
using the right and left anterior oblique views; the most
lateral region was reached (15 through the lateral and 10
through the posterolateral vein), and the final position was
validated on the basis of both the best left ventricular
stimulation threshold (1.48  0.81 V/0.5 ms; minimum
0.3 V; maximum 3.0 V) and the best left ventricular amplitude
signal. The right atrium and ventricle were then stimulated
by positioning standard bipolar catheters in the right atrial
appendage and right ventricular apex, respectively. During
cardioverter-defibrillator implantation, a dual-coil catheter
for right ventricular pacing, sensing, and cardioversion/
defibrillation was inserted in the right ventricle. The biven-
tricular pacing mode was programmed in DDD, and the
lower rate was set at 40 beats/min. The atrioventricular
interval was optimized for maximal diastolic filling by
Doppler echocardiography (17). In the control group, the
pacing mode was programmed in DDD, with a lower rate of
40 beats/min and an atrioventricular delay of 300 ms. If
these settings resulted in ventricular pacing, the device was
programmed in VVI, with lower rate at 40 beats/min.
Abbreviations and Acronyms
AUC  areas under the curve
CI  confidence interval
CRT  cardiac resynchronization therapy
ECG  electrocardiogram/electrocardiographic/
electrocardiography
EIVD  electrographic interventricular delay
ICC  intraclass correlation coefficient
IVD  interventricular delay
LBBB  left bundle branch block
LVEDVI  left ventricular end-diastolic volume index
LVEF  left ventricular ejection fraction
LVEMD  left ventricular electromechanical delay
LVESVI  left ventricular end-systolic volume index
MR  mitral regurgitation
MRa  mitral regurgitation area
MRd  mitral regurgitation duration
NYHA  New York Heart Association
ROC  receiver operating characteristic
SPWMD  septal-to-posterior wall motion delay
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At the site of the best left ventricular pacing, the local left
electrogram was recorded and the conduction time between
the right and left electrograms was calculated as a measure
of IVD (electrographic interventricular delay [EIVD]; ms).
CONTROL GROUP. Interventricular and intraventricular
asynchrony measures were analyzed in five patients with
chronic heart failure who, in accordance with another study
protocol, underwent device implantation followed by a
six-month period during which it was kept inactive. These
control subjects were used to evaluate whether the interven-
tricular and intraventricular asynchrony measures had any
post-implantation spontaneous modification not related to
CRT. Once again, the measurements at one month after
implantation were taken by operators who had no knowl-
edge of the baseline values.
Statistical analysis. The data are shown as the mean value
 SD. Continuous variables were compared using the t test,
and frequencies using the Fisher exact test. The percent
variations were compared using the Mann-Whitney U test.
Correlations between variables were assessed using Pear-
son’s linear correlation. Interobserver and intraobserver
reproducibilities were evaluated by means of the intraclass
correlation coefficient (ICC) (18), with reproducibility be-
ing considered almost perfect if the ICC was between 0.81
and 1.0. The receiver operating characteristics (ROC)
curves for sensitivity and specificity were constructed to
evaluate the predictive values of the studied variables, and
the areas under the curve (AUC) were statistically compared
to estimate the accuracy of the variables. The tests were
considered statistically significant at p  0.05.
RESULTS
We enrolled 25 patients: 5 with ischemic and 20 with
nonischemic heart disease (by World Health Organization
criteria) (19). The demographic, clinical, and therapeutic char-
acteristics of the patient population are shown in Table 1.
Reproducibility of echocardiographic asynchrony param-
eters. The intraobserver reproducibility of SPWMD,
LVEMD, and IVD (ICC: 0.96, 0.96, and 0.95, respective-
ly), as well as the interobserver reproducibility (ICC: 0.91,
0.92, and 0.83, respectively), was very high. The values of
these parameters before and one month after implantation
were similar to those of the control group, thus again
showing a very high degree of reproducibility (ICC: 0.97,
0.94, and 0.92, respectively).
Correlations between asynchrony parameters before im-
plantation. The baseline QRS duration significantly cor-
related only with SPWMD (r  0.62, p  0.01); LVEMD
and IVD did not correlate with the QRS interval,
SPWMD, or EIVD. Baseline EIVD significantly and
positively correlated with LVEMD (r  0.50, p  0.05),
but not with the QRS duration, SPWMD, or IVD.
Figure 1. Mono-dimensional short-axis view of the echocardiographic image taken at the level of the papillary muscles. Calculation of septal-to-posterior
wall motion delay (SPWMD) obtained by measuring the shortest interval between the maximal posterior displacement of the septum (a) and the posterior
wall (b).
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ECG and asynchrony parameters changes after CRT.
Changes in the electrocardiographically and echocardio-
graphically studied variables after one month of CRT are
shown in Table 2. As expected, there was a significant
reduction in the PQ interval and QRS duration, but no
significant change in the heart rate. There was a significant
reduction in all of the parameters reflecting intraventricular
and interventricular asynchrony, and left ventricular vol-
umes, ejection fractions, and MR significantly improved.
Correlations between baseline asynchrony parameters
and reverse remodeling. The SPWMD and QRS dura-
tion measures before implantation significantly correlated
with the reductions in both left ventricular end-diastolic
volume index (LVEDVI) (r  0.73, p  0.001 and r 
0.55, p  0.05, respectively) and LVESVI (Figs. 2 and 3)
(i.e., the longer the baseline SPWMD and QRS duration,
the greater the reverse remodeling). In contrast, LVEMD,
IVD, and EIVD did not significantly correlate with the
changes in left ventricular volumes.
Comparison between responders and nonresponders.
Twelve patients were responders (reduction in LVESVI
15%). At baseline, there were no differences between the
responders and nonresponders in terms of the heart rate,
QRS duration, ventricular volumes, and MR, but the
responders had a longer PQ interval and a longer SPWMD
(Table 3).
In Table 4, the percent variations of the studied param-
eters in responders and nonresponders are shown. The
reductions in LVEDVI, LVESVI, and MRa were signifi-
cantly greater in responders than in nonresponders. No
differences between the two groups were found when ECG
parameters, asynchrony measures, LVEF, and MRd varia-
tions were taken into account. Seventeen patients improved
in their NYHA functional class, from III to II. The
responders were more likely to improve their NYHA
functional class, as compared with nonresponders (100% vs.
63%; p  0.05).
Predictive value of asynchrony parameters. The ROC
curves for post-CRT reverse remodeling showed that the
AUC for SPWMD (0.95; confidence interval [CI] 0.76 to
0.99) was significantly greater than those for the QRS
duration (0.59; CI 0.35 to 0.80) (Fig. 4), LVEMD (0.60;
CI 0.34 to 0.83), IVD (0.68; CI 0.38 to 0.89), or EIVD
(0.54; CI 0.30 to 0.76), but not statistically different from
that of the PQ interval (0.78; CI 0.54 to 0.93). All of the
responders had a baseline SPWMD 130 ms, a QRS
duration150 ms, and a PQ interval180 ms. Using these
cut-off values, the specificity of SPWMD was 63%, with a
positive predictive value of 80% and an accuracy of 85%,
whereas the specificity of both the QRS duration and PQ
interval was 13%, with a positive predictive value of 63% and
an accuracy of 65%.
Table 1. Baseline Clinical Characteristics of All Patients, Responders, Nonresponders,
and Controls
All Patients
(n  25)
Responders
(n  12)
Nonresponders
(n  8)
Controls
(n  5)
Age (yrs) 62  11 65  10 61  11 60  12
Male/female (n) 11/14 4/8 4/4 3/2
NYHA functional class III III III III
Underlying cardiomyopathy (%)
Ischemic 20 0 50 20
Nonischemic 80 100 50 80
Concomitant therapy (%)
ACE inhibitors 80 75 75 100
AT1 receptor antagonists 20 25 13 0
Beta-blockers 76 67 88 80
Digitalis 72 83 50 80
Diuretics 100 100 100 100
Aldosterone antagonists 72 75 63 80
Data are presented as the mean value  SD, number, or percentage of patients.
ACE  angiotensin-converting enzyme; AT1  angiotensin type 1; NYHA  New York Heart Association.
Table 2. Differences in Electrocardiographic and
Echocardiographic Parameters Before and After One Month of
Cardiac Resynchronisation Therapy
Before CRT
(n  20)
One Month
After CRT
(n  20) p Value
Heart rate (beats/min) 71  14 68  11 NS
PQ interval (ms) 203  28 125  19  0.0001
QRS duration (ms) 169  16 132  12  0.0001
SPWMD (ms) 192  92 14  67  0.0001
LVEMD (ms) 167  35 141  27  0.05
IVD (ms) 59  29 39  21  0.05
LVEDVI (ml/m2) 150  53 119  37  0.001
LVESVI (ml/m2) 116  43 85  29  0.0001
LVEF (%) 24  5 29  6  0.001
MRd (ms) 560  59 470  59  0.0001
MRa (mm
2) 10.4  3.7 6.6  3.4  0.01
Data are presented as the mean value  SD.
CRT  cardiac resynchronization therapy; IVD  difference between LVEMD
and right ventricular electromechanical delay (interval between onset of QRS and
onset of pulmonary flow); LVEDVI  left ventricular end-diastolic volume indexed
for body surface area; LVEF  left ventricular ejection fraction; LVEMD  left
ventricular electromechanical delay (interval between onset of QRS and onset of aortic
flow); LVESVI  left ventricular end-systolic volume indexed for body surface area;
MRa  mitral regurgitation area; MRd  mitral regurgitation duration; SPWMD 
septal-to-posterior wall motion delay.
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DISCUSSION
Cardiac resynchronization has recently been proposed as a
long-term treatment for patients with severe heart failure
despite optimal medical therapy. This electrical strategy is
currently offered to patients with complete LBBB in the
belief that this ECG parameter reflects mechanical asyn-
chrony (1,2), but a benefit in terms of improved symptoms
and ventricular reverse remodeling is evident in only some
patients (6–8).
The main result of the present study is that an echocar-
diographically derived measure of intraventricular mechan-
ical asynchrony identifies patients with severe heart failure
who are likely to show reverse remodeling more accurately
than LBBB alone. The relevance of our findings comes
from the fact that they are the result of pathophysiologic
speculation (1–3,20), and this sheds new light on the
possibility of changing the selection criteria used to identify
heart failure patients suitable for CRT.
Left ventricular remodeling is the result of the complex
interaction between structural and functional abnormalities
favoring the progressive dilation of the left ventricle (21),
which takes on a spherical shape that is unfavorable from an
energetic point of view and becomes dyssynergic (i.e., the
posterolateral wall contracts later than does the septum).
These abnormalities are responsible for MR and further
hemodynamic deterioration (22) and are worsened by the
appearance of LBBB (2). It is believed that stimulation of
the left posterolateral wall in order to synchronize this area
with the septum blunts these alterations and gives rise to
so-called “reverse remodeling.”
However, the possibility of achieving this favorable result
depends on a number of factors, such as the presence of a
left ventricular area with delayed contraction, the possibility
Figure 2. Two-dimensional apical four-chamber view of echocardiographic images. Left ventricular end-systolic volumes before (pre) device implantation
(left images) and one month after cardiac resynchronization therapy (right images) in two different patients. (A) This patient had a prolonged
pre-implantation septal-to-posterior wall motion delay (SPWMD) and a marked left ventricular end-systolic volume reduction after one month. (B) This
patient had a short pre-implantation SPWMD and no reverse remodeling.
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of identifying it, and, finally, the ability to reach and
stimulate this area by using a catheter positioned through
the coronary sinus. The first two factors are particularly
relevant for guiding patient selection. On the basis of these
considerations and our results, it is possible to hypothesize
that nonresponders are the consequence of inadequate
patient selection, which is currently based on the presence of
LBBB (13). This ECG abnormality should be considered as
only a generic marker of conduction disturbance, because
the fact that left intraventricular asynchrony is often asso-
ciated with LBBB is not sufficient to presume that the latter
is a specific marker of any degree of mechanical asynchrony.
Also, LBBB may be the result of abnormalities that do not
necessarily cause late contraction of the left free wall (e.g.,
peripheral conduction defect or global left ventricular dys-
function).
Seen in this light, the weak correlation between QRS
duration and echocardiographically visualized mechanical
asynchrony is not surprising. Furthermore, our hypothesis
explains the low specificity of even a very wide QRS interval
(as in the case of our patient population) in predicting the
occurrence of reverse remodeling. In contrast, by providing
information on the delayed mechanical asynchrony between
the left free wall and septum, the echocardiographic param-
eter is highly specific and has a positive predictive value: the
longer the delay, the greater the reduction in ventricular
volumes.
The parameter analyzing IVD by taking into account the
onset of the QRS interval and aortic flow does not provide
the same information as that of SPWMD. It is possible that
this measure is not sufficiently precise to identify the
presence of delayed left free wall contraction and, in
particular, its asynchrony with the septum. This echocar-
diographic Doppler parameter correlates well with the
electrical delay recorded between the right and left catheter
during implantation. In addition, EIVD is not useful in
predicting reverse remodeling. The electrogram recorded at
Table 3. Comparison of Baseline Characteristics of Responders
and Nonresponders
Responders
(n  12)
Nonresponders
(n  8) p Value
ECG parameters
Heart rate (beats/min) 68  15 76  12 NS
PQ interval (ms) 213  27 186  23  0.05
QRS duration (ms) 173  18 164  12 NS
Echocardiographic
parameters
SPWMD (ms) 246  68 110  55  0.001
LVEMD (ms) 176  40 163  55 NS
IVD (ms) 59  19 73  21 NS
LVEDVI (ml/m2) 162  65 132  23 NS
LVESVI (ml/m2) 125  52 103  19 NS
LVEF (%) 24  4 23  5 NS
MRd (ms) 559  63 561  58 NS
MRa (mm
2) 9.8  1.8 10.2  5.5 NS
Data are presented as the mean value  SD.
ECG  electrocardiographic; other abbreviations as in Table 2.
Table 4. Comparison of One-Month Percent Variations
Occurring in the Studied Parameters Between Responders and
Nonresponders
Responders
(n  12)
Nonresponders
(n  8)
p
Value
ECG parameter changes (%)
Heart rate 1  19 7  10 NS
PQ interval 39  11 36  8 NS
QRS duration 21  9 22  10 NS
Echocardiographic parameter
changes (%)
SPWMD 97  37 85  56 NS
LVEMD 4  13 21  32 NS
IVD 16  32 42  32 NS
LVEDVI 29  12 2  4  0.05
LVESVI 36  12 8  5  0.05
LVEF 27  18 18  32 NS
MRd 44  12 21  28 NS
MRa 19  10 11  7  0.05
Data are presented as the mean value  SD.
ECG  electrocardiographic; other abbreviations as in Table 2.
Figure 3. (Top) The correlation between the baseline values of septal-to-
posterior wall motion delay (SPWMD) and LVESVI. (Bottom) Corre-
lation between baseline QRS duration and LVESVI. LVESVI 
difference between post- and pre-implantation left ventricular end-systolic
volumes indexed for body surface area.
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the level of the lateral free wall is greatly influenced by the
position of the catheter in the coronary sinus tree and,
therefore, by its anatomy. Furthermore, in patients with a
previous myocardial infarction, the presence of slowed
conduction in the peri-infarcted myocardium may give rise
to a locally prolonged delay that does not reflect real
intraventricular asynchrony.
Another interesting finding is the very high predictive
value of the baseline PQ interval: the longer the interval, the
greater the improvement. It has been previously suggested
that prolonged atrioventricular conduction has pathophysi-
ologic significance (23–25) and may lead to worsening
hemodynamic function that is independent of intraventric-
ular asynchrony (26). Although the number of patients
enrolled in this study did not allow us to perform multivar-
iate analysis, analysis of the independent and incremental
value of these parameters would be of interest in defining
patient selection criteria.
To the best of our knowledge, this is the first study that
has prospectively demonstrated the value of electrocardio-
graphically and echocardiographically derived Doppler mea-
sures in predicting reverse remodeling in patients receiving
CRT. However, it must to be acknowledged that Stellbrink
et al. (7) have recently suggested that patients with very
large left ventricular volumes at baseline are unlikely to
benefit from CRT. This hypothesis was not confirmed in
our patient population, because a long SPWMD retained its
ability to predict improvement, even in the presence of a
very dilated heart. This difference may be due to the fact
that Stellbrink et al. (7) analyzed ventricular volumes with-
out considering the degree of left lateral wall motion delay.
Therefore, it is possible that their patients with very dilated
ventricles had global hypokinesia with little intraventricular
asynchrony (a phenomenon that is not unusual in markedly
remodeled hearts).
The intraventricular asynchrony parameter we suggest
combines the advantages of the echocardiographic tech-
nique with a high level of accuracy in identifying responders.
It is therefore a very promising measure in the clinical
setting. The use of mono-dimensional echocardiography to
evaluate all patients with severe heart failure, LBBB, and a
wide QRS interval would make it possible to avoid implant-
ing the device in those whose cardiac function is unlikely to
improve.
Conclusions. This study suggests that patients with stable
and severe heart failure (while receiving optimal therapy)
and LBBB need to be further evaluated echocardiographi-
cally to identify the possible presence of a long SPWMD,
which would allow the selection of patients most likely to
achieve reverse remodeling after CRT. However, LBBB
alone (even if the QRS duration is very prolonged) cannot
be considered an adequate marker of intraventricular asyn-
chrony and, therefore, cannot be used as the only parameter
guiding the decision to implant a biventricular device.
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